| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.35 |
4e-18 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
6e-16 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
8e-13 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-12 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |